Hodgkin Lymphoma: Biopsy, Resection | ||
Surgical Pathology Cancer Case Summary (Checklist) | ||
Specimen (select all that apply) | ||
____ Lymph node(s) | ||
____ Other (specify): ______________________________ | ||
____ Not specified | ||
Procedure | ||
____ Biopsy | ||
____ Resection | ||
____ Other (specify): ______________________________ | ||
____ Not specified | ||
Tumor Site (select all that apply) | ||
____ Lymph node(s), site not specified | ||
____ Lymph node(s) | ||
Specify site(s): ______________________________ | ||
____ Other tissue(s) or organ(s) (specify): ______________________________ | ||
____ Not specified | ||
Histologic Type (based on 2008 WHO classification) | ||
____ Hodgkin lymphoma, histologic subtype cannot be determined | ||
____ Classical Hodgkin lymphoma, histologic subtype cannot be determined | ||
____ Nodular lymphocyte predominant Hodgkin lymphoma | ||
____ Nodular sclerosis classical Hodgkin lymphoma | ||
____ Mixed cellularity classical Hodgkin lymphoma | ||
____ Lymphocyte-rich classical Hodgkin lymphoma | ||
____ Lymphocyte-depleted classical Hodgkin lymphoma | ||
*Pathologic Extent of Tumor (select all that apply) | ||
*____ Involvement of a single lymph node region | ||
*Specify sites: ______________________________ | ||
*____ Involvement of ≥ 2 lymph node regions on same side of diaphragm | ||
*Specify sites: ______________________________ | ||
*____ Involvement of lymph node regions on both sides of diaphragm | ||
*Specify sites: ______________________________ | ||
*____ Spleen involvement | ||
*____ Liver involvement | ||
*____ Bone marrow involvement | ||
*____ Other site involvement | ||
*Specify site(s): ______________________________ | ||
*Additional Pathologic Findings | ||
*Specify: ______________________________ | ||
Immunophenotyping (immunohistochemistry) | ||
____ Performed, see separate report: ______________________________ | ||
____ Performed | ||
Specify method(s) and results: ______________________________ | ||
____ Not performed | ||
*Clinical Prognostic Factors and Indices (select all that apply) | ||
*____ International Prognostic Score (IPS) (specify): __________ | ||
*____ B symptoms present | ||
*____ Other (specify): ______________________________ | ||
Adapted with permission from College of American Pathologists, “Protocol for the Examination of Specimens from Patients with Hodgkin Lymphoma.” Web posting date October 2009, www.cap.org. |
Protocol for Examination of Hodgkin Lymphoma Specimens
Protocol for Examination of Hodgkin Lymphoma Specimens
L. Jeffrey Medeiros, MD